>
China Resources Medical Holdings logo

1515 - China Resources Medical Holdings Share Price

HK$6.66 -0.2  -3.3%

Last Trade - 07/05/21

Sector
Healthcare
Size
Mid Cap
Market Cap £800.7m
Enterprise Value £579.2m
Revenue £306.7m
Position in Universe 1007th / 6096
Bullish
Bearish
Unlock 1515 Revenue
Momentum
Relative Strength (%)
1m +3.86%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -20.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
1,372 1,533 1,878 2,059 2,115 2,751 2,892 3,131 +14.9%
-24.0 -12.2 -8.1 -22.0 +38.1 +11.6
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, ChinaResources Medical Holdings Co Ltd revenues increased 30% toRMB2.75B. Net income decreased 21% to RMB310.1M. Revenuesreflect an increase in demand for the Company's productsand services due to favorable market conditions. Net incomewas offset by Administrative expenses increase of 36% toRMB323.4M (expense), Bad Debt Written Off/Provisionincrease from RMB1.6M to RMB19.9M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

1515 Revenue Unlock 1515 Revenue

Net Income

1515 Net Income Unlock 1515 Revenue

Normalised EPS

1515 Normalised EPS Unlock 1515 Revenue

PE Ratio Range

1515 PE Ratio Range Unlock 1515 Revenue

Dividend Yield Range

1515 Dividend Yield Range Unlock 1515 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
1515 EPS Forecasts Unlock 1515 Revenue
Profile Summary

China Resources Medical Holdings Company Limited, formerly China Resources Phoenix Healthcare Holdings Co., Ltd, is an investment holding company mainly engaged in the group purchasing organization (GPO) business. Along with subsidiaries, the Company operates its business through four segments. The GPO Business segment is involved in the sales of pharmaceuticals, medical devices and medical consumables to Jian Gong Hospital, the Internet of things (IOT) Hospitals and external customers. The General Healthcare Services segment provides hospital services provided through Jian Gong Hospital and 999 Medical Clinic (Shenzhen) Co., Ltd. The Hospital Management and Consulting Services segment provides comprehensive management and consulting services to IOT Hospitals and sponsored hospitals and receives an annual fee. The Other Hospital-Derived Services segment provides medical consultation service to third parties.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated February 28, 2013
Public Since November 29, 2013
No. of Shareholders: n/a
No. of Employees: 4,843
Sector Healthcare
Industry Healthcare Providers & Services
Index Hang Seng Composite , Hang Seng Composite Mid & SmallCap , Hang Seng Composite SmallCap ,
Exchange Stock Exchange of Hong Kong Limited
Shares in Issue 1,296,676,516
Free Float (0.0%)
Eligible for
ISAs
SIPPs
1515 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 1515
Upcoming Events for 1515
Friday 28th May, 2021 Estimate
China Resources Medical Holdings Co Ltd Annual Shareholders Meeting
Thursday 3rd June, 2021
China Resources Medical Holdings Company Ltd Annual Shareholders Meeting
Monday 7th June, 2021
Dividend For 1515.HK - 0.0882 HKD
Frequently Asked Questions for China Resources Medical Holdings
What is the China Resources Medical Holdings share price?

As of 07/05/21, shares in China Resources Medical Holdings are trading at HK$6.66, giving the company a market capitalisation of £800.7m. This share price information is delayed by 15 minutes.

How has the China Resources Medical Holdings share price performed this year?

Shares in China Resources Medical Holdings are currently trading at HK$6.66 and the price has moved by 64.85% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the China Resources Medical Holdings price has moved by 4.28% over the past year.

What are the analyst and broker recommendations for China Resources Medical Holdings?

Of the analysts with advisory recommendations for China Resources Medical Holdings, there are there are currently 1 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for China Resources Medical Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will China Resources Medical Holdings next release its financial results?

China Resources Medical Holdings is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the China Resources Medical Holdings dividend yield?

The China Resources Medical Holdings dividend yield is 1.34% based on the trailing twelve month period.

Does China Resources Medical Holdings pay a dividend?

Last year, China Resources Medical Holdings paid a total dividend of 0.07, and it currently has a trailing dividend yield of 1.34%. Looking ahead, shares in China Resources Medical Holdings are due to go ex-dividend on 2021-06-07 and the next dividend pay date is 2021-06-23.

When does China Resources Medical Holdings next pay dividends?

China Resources Medical Holdings are due to go ex-dividend on 2021-06-07 and the next dividend pay date is 2021-06-23. The historic dividend yield on China Resources Medical Holdings shares is currently 1.34%.

How do I buy China Resources Medical Holdings shares?

To buy shares in China Resources Medical Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of China Resources Medical Holdings?

Shares in China Resources Medical Holdings are currently trading at HK$6.66, giving the company a market capitalisation of £800.7m.

Where are China Resources Medical Holdings shares listed? Where are China Resources Medical Holdings shares listed?

Here are the trading details for China Resources Medical Holdings:

Country of listing: Hong Kong
Exchange: HKG
Ticker Symbol: 1515
What kind of share is China Resources Medical Holdings?

Based on an overall assessment of its quality, value and momentum, China Resources Medical Holdings is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a China Resources Medical Holdings share price forecast 2021?

Shares in China Resources Medical Holdings are currently priced at HK$6.66. At that level they are trading at 1.05% premium to the analyst consensus target price of 0.00.

Analysts covering China Resources Medical Holdings currently have a consensus Earnings Per Share (EPS) forecast of 0.336 for the next financial year.

How can I tell whether the China Resources Medical Holdings share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like China Resources Medical Holdings. Over the past six months, the relative strength of its shares against the market has been 11.11%. At the current price of HK$6.66, shares in China Resources Medical Holdings are trading at 11.2% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the China Resources Medical Holdings PE Ratio?

The China Resources Medical Holdings PE ratio based on its reported earnings over the past 12 months is 22.76. The shares are currently trading at HK$6.66.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of China Resources Medical Holdings?

China Resources Medical Holdings's management team is headed by:

Zechang Xu - GMG
Kwok Kong Kwong - NID
Libing Cheng - CEO
Qianjin Chen - OTH
Wing Kee Or - OTH
Kar Chung Lee - NID
Wang Yan - NED
Yuan Ren - CFO
Yanjun Fu - EDR
Kam Hing Chiu - NID
Yiu Fung So - SEC
Qing Song - CHM
Who are the major shareholders of China Resources Medical Holdings?

Here are the top five shareholders of China Resources Medical Holdings based on the size of their shareholding:

China Resources Co Ltd Corporation
Percentage owned: 36.58% (474.3m shares)
First Sentier Investors (Hong Kong) Limited Investment Advisor
Percentage owned: 9.92% (128.6m shares)
First Sentier China Growth Fund Mutual Fund
Percentage owned: 4.85% (62.8m shares)
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund
Percentage owned: 1.32% (17.1m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 1.29% (16.7m shares)
Similar to 1515
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.